Tom F Brouwer
Overview
Explore the profile of Tom F Brouwer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olde Nordkamp L, Pepplinkhuizen S, Ghani A, Boersma L, Kuschyk J, El-Chami M, et al.
Circ Arrhythm Electrophysiol
. 2024 Dec;
17(12):e012836.
PMID: 39624908
Background: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The...
2.
Knops R, de Veld J, Ghani A, Boersma L, Kuschyk J, El Chami M, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e010822.
PMID: 39561235
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome the risk of lead-related complications associated with the transvenous implantable cardioverter-defibrillator (TV-ICD). In contrast to the TV-ICD, the S-ICD is...
3.
Knops R, El-Chami M, Marquie C, Nordbeck P, Quast A, Tilz R, et al.
Heart Rhythm
. 2024 Feb;
21(6):836-844.
PMID: 38336193
Background: The PRAETORIAN score estimates the risk of failure of subcutaneous implantable cardioverter-defibrillator (S-ICD) therapy by using generator and lead positioning on bidirectional chest radiographs. The PRospective randomized compArative trial...
4.
Ibrahim S, Nurmohamed N, Collard D, de Weger A, Hovingh G, van den Born B, et al.
J Am Heart Assoc
. 2023 Nov;
12(22):e031418.
PMID: 37947117
Background: Medication nonadherence contributes to poor health outcomes but remains challenging to identify. This study assessed the association between self-rated adherence and systolic blood pressure, low-density lipoprotein cholesterol levels, cardiovascular...
5.
Voltage gradients in transvenous and subcutaneous defibrillation and their risk of myocardial damage
Belalcazar A, Stahl W, Friedman D, Brouwer T, Knops R, Poole J, et al.
J Cardiovasc Electrophysiol
. 2023 Jun;
34(7):1561-1568.
PMID: 37330678
Introduction: Transvenous implantable cardioverter-defibrillator (ICD) shocks have been associated with cardiac biomarker elevations and are thought in some cases to contribute to adverse clinical outcomes and mortality, possibly from myocardium...
6.
Knops R, Pepplinkhuizen S, Delnoy P, Boersma L, Kuschyk J, El-Chami M, et al.
Eur Heart J
. 2022 Aug;
43(47):4872-4883.
PMID: 36030464
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD (TV-ICD) therapy. The PRAETORIAN trial demonstrated that the S-ICD is non-inferior...
7.
Knops R, van der Stuijt W, Delnoy P, Boersma L, Kuschyk J, El-Chami M, et al.
Circulation
. 2021 Nov;
145(5):321-329.
PMID: 34779221
Background: The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed noninferiority of subcutaneous implantable cardioverter defibrillator (S-ICD) compared with transvenous implantable cardioverter defibrillator...
8.
van der Stuijt W, Quast A, Baalman S, de Wilde K, Brouwer T, Wilde A, et al.
Europace
. 2020 Nov;
23(3):395-399.
PMID: 33197266
Aims: To guarantee uninterrupted function of the subcutaneous implantable cardioverter-defibrillator (S-ICD), the pulse generator needs to be surgically replaced before the battery is depleted. The risks related to this replacement...
9.
Knops R, Olde Nordkamp L, Delnoy P, Boersma L, Kuschyk J, El-Chami M, et al.
N Engl J Med
. 2020 Aug;
383(6):526-536.
PMID: 32757521
Background: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based...
10.
van der Stuijt W, Baalman S, Brouwer T, Quast A, de Groot J, Knops R
Pacing Clin Electrophysiol
. 2020 Jul;
43(12):1476-1480.
PMID: 32720398
Introduction: The two-incision implantation technique of the subcutaneous implantable cardioverter-defibrillator (S-ICD) was introduced as an alternative to the standard three-incision approach by omitting the superior parasternal incision. Thereby, complications may...